Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety, tolerability, and efficacy of
Interferon gamma-1b (IFN-gamma 1b) when administered by subcutaneous injection over a period
of 4 weeks to patients with mild-to-moderate cystic fibrosis. Additionally, preliminary
assessments on the effects of IFN-gamma 1b on lung function and other indicators of health
will be made.